Announcements Trials
Browse Landscape

Phase

Phase 1 43Phase 2 15Phase 1/2 6Phase NA 2Phase 3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 2

Sponsor Class

OTHER 73INDUSTRY 44NETWORK 5OTHER_GOV 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 93Breast 86Other hematologic neoplasm 63Lymphoid 63Genitourinary 56Thoracic 54Gynecologic 35CNS 28Sarcoma 26Plasma cell 25Dermatologic 25Head & Neck 21Myeloid 17Classical hematology 13Other solid neoplasm 4Other 4Other neoplasm 3Endocrine 3Tumor-Agnostic 2NET 2

Conditions

Neoplasms, Unknown Primary 2

Interventions

Fluorouracil 2Vincristine 1Paclitaxel 1Leucovorin 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × NIH × Tumor-Agnostic × Clear all
NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

National Cancer Institute (NCI)

Phase 3 Unknown
140 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡